Radiotracers targeting increased amino acid transporter expression can also be used for tumour detection, in some cases improving tumour contrast compared to [18F]FDG, or providing additional prognostic information (Pantel et al. 2018; Huang and McConathy 2013; McConathy and Goodman 2008). This evidence concerns the gene SLC38A7 and neoplasm.